3.700SEK+4.08%Mkt Cap: 680.94M SEKP/E: —Last update: 2026-05-13
Nanexa AB (publ), a pharmaceutical company, develops injectable drug products in the Nordic countries, Europe, Asia, and North America. The company offers PharmaShell, a drug delivery system based on atomic layer deposit…
Industry Peers
Drug Manufacturers - Specialty & Generic153.14BSEKP/E 167.7
58.14BTRYP/E 27.8
51.02BEURP/E 20.1
13.68BEURP/E 31.2
13.35BTRY—
13.10BSEKP/E 39.5
3.09BTRY—
3.02BEURP/E 25.0
loading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)16.75
PEG—
P/B5.91
P/S12.17
EV/EBITDA-235.70
EV/Revenue9.22
EPS (TTM)-0.09
EPS (Forward)0.22
Cash Flow & Leverage
FCF Yield-0.26%
FCF Margin-3.19%
Operating CF-1.46M SEK
CapEx (TTM)24.75M SEK
Net Debt/EBITDA19.36
Net Debt-42.37M SEK
Technical
SMA 503.724 (-0.6%)
SMA 2002.969 (+24.6%)
Beta1.86
S&P 52W Chg24.23%
Avg Vol (30d)578.56K
Avg Vol (10d)447.06K
Technical Indicators
RSI (14)51.4
MACD-0.0469
MACD Signal-0.0540
MACD Hist.+0.0071
BB Upper3.993 SEK
BB Middle3.659 SEK
BB Lower3.326 SEK
BB Width18.20%
ATR (14)0.2118 SEK
Vol Ratio (20d)0.88x
52W Range
1.40064% of range5.000
52W High5.000 SEK
52W Low1.400 SEK
Profitability
Gross Margin154.74%
EBITDA Margin-3.91%
Profit Margin-31.50%
Oper. Margin49.72%
ROE-11.22%
ROA-8.24%
Revenue Growth222.30%
Earnings Growth—
Balance Sheet
Debt/Equity0.02
Current Ratio1.51
Quick Ratio1.42
Book Value/Sh0.6240 SEK
Cash/Share0.2740 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Ownership
Shares Out.184.79M
Float118.49M
Insiders43.63%
Institutions2.78%
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Company
Market Cap680.94M SEK
Enterprise Value515.95M SEK
Revenue (TTM)55.94M SEK
Gross Profit55.94M SEK
Net Income (TTM)-11.39M SEK
Revenue/Share0.3590 SEK
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees15
Last Price3.700 SEK
CountrySE
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—